Lyu, Shiqing
Li, Qiutong
Gu, Zhiyue
Yan, Hailan
Tang, Xinyue
Dai, Yi
Li, Xiaoyan
Wu, Yushi
Zhang, Chenyu
Xu, Yiyao
Li, Yuanyuan
Hu, Yao
Wong, Wing Hing
Yu, Yanqin
Lu, Shen
Bischoff, Farideh Z.
Leng, Jinhua
Shi, Jinghua
Funding for this research was provided by:
Fundamental Research Funds for the Central Universities, Peking Union Medical College (3332025123)
Key Technologies Research and Development Program (2022YFC2704000)
National Key Clinical Specialty Construction Project (U114000)
Article History
Received: 12 November 2025
Accepted: 21 January 2026
First Online: 25 January 2026
Declarations
:
: Y.H., W.H.W., Y.Y., S.L. and F.B. are employees of HerAnova Lifesciences. FB holds stock options of the company. The authors declare no other conflicts of interest, financial or otherwise.